Page 2 - Drugmaker

Moderna shares soar over 16% over coronavirus vaccine trial result

All the 45 patients in the trial produced neutralising antibodies which are believed to be important for building immunity

Drugmakers slash prices to be eligible for China's bulk-buy program

Sale prices of over 100 types of commonly used drugs are on average about 17 to 18 times of their manufacturing costs, the statement said

Drugmakers from Pfizer to GSK to hike US prices up to 10% on over 200 drugs

More price increases are expected to be announced later this week, which could affect the median and range.

MNCs, domestic drug makers did equally well in terms of growth rate

The data shows that in the last 12 months, multinational drugmakers have also done equally well in the Indian market in terms of growth rate

Medicines costing less than Rs 5 per dose may be taken out of price control

If this goes through, drugmakers will have the liberty to raise the prices of these drugs by up to 10 per cent every year

Dr Reddy's Labs looks to recover from Q1 blues with multiple growth drivers

Steady improvement in the US and India market growth keeps analysts positive

Drug companies step up global investments to tap biosimilars

Cipla is investing Rs 600 crore to set up a manufacturing plant for biosimilars in South Africa

Delhi High Court grants temporary relief to Abbott, Glenmark in drug ban case

Govt banned 344 drug combinations over weekend, including Abbott's codeine-based cough syrup